Associated expressions of FGFR-2 and FGFR-3: From mouse mammary gland physiology to human breast cancer

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 997-1008

  Cerliani, Juan P ^a   Vanzulli, Silvia I ^b   Piñero, Cecilia Pérez ^a   Bottino, María C ^a   Sahores, Ana ^a   Nuñez, Myriam ^c   Varchetta, Romina ^d   Martins, Rubén ^d   Zeitlin, Eduardo ^d   Hewitt, Stephen M ^e   Molinolo, Alfredo A ^f   Lanari, Claudia ^a   Lamb, Caroline A ^a  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Policlinica Bancaria   (Argentina)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Breast cancer; Fibroblast growth factor receptors; Mammary carcinomas; Mammary glands

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GESTAGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; BREAST DEVELOPMENT; CANCER CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT;

ADULT; AGED; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; MIDDLE AGED; PREGNANCY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; TRANSPLANTATION, HETEROLOGOUS;

EID: 84863726758     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1883-6     Document Type: Article

References (49)

1. Morrison RS, Yamaguchi F, Bruner JM et al (1994) Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 54:2794-2799
2. Yoshimura N, Sano H, Hashiramoto A et al (1998) The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 89:28-34
3. Giri D, Ropiquet F, Ittmann M (1999) Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5:1063-1071
4. Ahmed NU, Ueda M, Ito AM et al (1997) Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma. Melanoma Res 7:299-305
5. Myoken Y, Myoken Y, Okamoto T et al (1996) Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth. Int J Cancer 65:650-657
6. Shingu K, Fujimori M, Ito K et al (1998) Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions. Endocr J 45:35-43
7. Bernard RS, Zheng L, Liu W et al (2005) Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. Endocrinology 146:1145-1153
8. Powers CJ, McLeskey SW, Wellstein A (2000) Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7: 165-197
9. Hynes NE, Dey JH (2010) Potential for targeting the fibroblast growth factor receptors in breast cancer. Cancer Res 70:5199-5202
10. Giulianelli S, Cerliani JP, Lamb CA et al (2008) Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis. Int J Cancer 123:2518-2531
11. Cerliani JP, Guillardoy T, Giulianelli S et al (2011) Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer. Cancer Res 71:3720-3731
12. Imagawa W, Pedchenko VK, Helber J et al (2000) Attenuation and loss of hormonal modulation of KGF (FGF-7)/KGF receptor expression and mitogenesis during mammary tumor progression. J Cell Physiol 184:222-228
13. Ishii K, Imamura T, Iguchi K et al (2009) Evidence that andro-gen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo. Endocr Relat Cancer 16:415-428
14. Chodosh LA, Gardner HP, Rajan JV et al (2000) Protein kinase expression during murine mammary development. Dev Biol 219:259-276
15. Shiang CY, Qi Y, Wang B et al (2010) Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate. Breast Cancer Res Treat 123:747-755
16. Turner N, Pearson A, Sharpe R et al (2010) FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res 70:2085-2094
17. Institute of Laboratory Animal Resources CoLSNRC (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC
18. Lanari C, Lamb CA, Fabris VT et al (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333-350
19. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377
20. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histo-pathology 19:403-410
21. Vanzulli SI, Soldati R, Meiss R et al (2005) Estrogen or anti-progestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression. Carcinogenesis 26:1055-1063
22. Molinolo AA, Hewitt SM, Amornphimoltham P et al (2007) Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 13:4964-4973
23. Helguero LA, Viegas M, Asaithamby A et al (2003) Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment. Breast Cancer Res Treat 79:379-390
24. Brisken C, O'Malley B (2010) Hormone action in the mammary gland. Cold Spring Harb Perspect Biol 2:a003178
25. Montero GG, Vanzulli SI, Cerliani JP et al (2007) Association of estrogen receptor alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment. Breast Cancer Res 9:R22
26. Pandit SG, Govindraj P, Sasse J et al (2002) The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs. Biochem J 361:231-241
27. Zhu X, Asa SL, Ezzat S (2009) Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. Mol Endocrinol 23:1397-1405
28. Hollestelle A, Nagel JH, Smid M et al (2010) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat 121:53-64
29. Bruzzone A, Vanzulli SI, Soldati R et al (2009) Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice. J Cell Physiol 219:477-484
30. Lu P, Ewald AJ, Martin GR et al (2008) Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 321: 77-87
31. Parsa S, Ramasamy SK, De Langhe S et al (2008) Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev Biol 317:121-131
32. Pond AC, Herschkowitz JI, Schwertfeger KL et al (2010) Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Res 70:4868-4879
33. Johnston CL, Cox HC, Gomm JJ et al (1995) Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J Biol Chem 270:30643-30650
34. Tannheimer SL, Rehemtulla A, Ethier SP (2000) Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res 2:311-320
35. Luqmani YA, Graham M, Coombes RC (1992) Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 66:273-280
36. Turner N, Lambros MB, Horlings HM et al (2010) Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 29:2013-2023
37. Fillmore CM, Gupta PB, Rudnick JA et al (2010) Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci USA 107:21737-21742
38. Thussbas C, Nahrig J, Streit S et al (2006) FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol 24:3747-3755
39. Bange J, Prechtl D, Cheburkin Y et al (2002) Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62:840-847
40. Sharpe R, Pearson A, Herrera-Abreu MT et al (2011) FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo. Clin Cancer Res 17:5275-5286
41. Gelsi-Boyer V, Orsetti B, Cervera N et al (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3:655-667
42. Gowardhan B, Douglas DA, Mathers ME et al (2005) Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer. Br J Cancer 92:320-327
43. Martin AJ, Grant A, Ashfield AM et al (2011) FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype. BMC Res Notes 4:72
44. Zammit C, Barnard R, Gomm JC et al (2001) Altered intracel-lular localization of fibroblast growth factor receptor 3 in human breast cancer. J Pathol 194:27-34
45. Kuroso K, Imai Y, Kobayashi M et al (2010) Immunohisto-chemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/mole-cular parameters and prognosis. Pathobiology 77:231-240
46. Zhu X, Asa SL, Ezzat S (2010) Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer. Am J Pathol 176:2333-2343
47. Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093
48. Marian C, Ochs-Balcom HM, Nie J et al (2010) FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors. Int J Cancer 129:702-712
49. Garcia-Closas M, Chanock S (2008) Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 14:8000-8009